via Phys.org
Heart attack, or myocardial infarction, is one of the leading causes of death worldwide. Although modern surgical techniques, diagnostics and medications have greatly improved early survival from these events, many patients struggle with the long-term effects of permanently damaged tissue, and the 5-year mortality rate remains high.
Now, researchers reporting in ACS Nano have developed a minimally invasive exosome spray that helped repair rat hearts after myocardial infarction.
Scientists have explored using stem cell therapy as a way to regrow tissue after a heart attack. But introducing stem cells directly to the heart can be risky because they could trigger an immune response or grow uncontrollably, resulting in a tumor. Therefore, researchers have tried injecting exosomes –– membrane-bound sacs containing proteins, lipids and nucleic acids secreted by stem cells –– into the heart, but they often break down before they can have therapeutic effects. Others have developed cardiac patches, or scaffolds that help implanted exosomes last longer, but they usually must be placed on the heart during open-chest surgery. Yafeng Zhou and colleagues wanted to develop an exosome solution that could be sprayed onto the heart through a tiny incision, avoiding major surgery.
The researchers mixed exosomes from mesenchymal stem cells with fibrinogen, a protein involved in blood clotting. They added this solution to a tiny, double-barreled syringe that contained a separate solution of another clotting protein called thrombin. When the team sprayed the solutions out of the syringe onto a rat’s heart through a small chest incision, the liquids mixed and formed an exosome-containing gel that stuck to the heart. A mini-endoscope, inserted through a second small incision, guided the spray needle. In rats that had recently had a heart attack, the exosome spray lasted longer, healed injuries better and boosted the expression of beneficial proteins more than heart-injected exosomes. In pigs, the spray caused less severe immune reactions and surgical stress than open-chest surgery. The spray is a promising strategy to deliver therapeutic exosomes for heart repair, the researchers say.
Original Article: New spray could someday help heal damage after a heart attack
More from: American Chemical Society
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Exosome spray to repair hearts
- HMD’s Pulse smartphones are the company’s first to shun the Nokia brand
While Nokia used to be one of the biggest names in the cellphone world, that hasn’t been the case for years. Nokia sold its smartphone division to Microsoft in 2014 and licensed the Nokia name to HMD ...
- Heart pumps recalled after reports of 14 deaths, over 270 injuries: FDA
The FDA announced Monday that two heart pump products are being recalled after reports of 14 deaths and hundreds of injuries were associated with the devices.
- FDA announces recall of heart pumps linked to deaths and injuries
The recall comes years after surgeons say they first noticed problems with the HeartMate II and HeartMate 3, manufactured by Thoratec Corp., a subsidiary of Abbott Laboratories.
Go deeper with Google Headlines on:
Exosome spray to repair hearts
[google_news title=”” keyword=”exosome spray to repair hearts” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Heart attack treatment
- Adena patient thankful after massive heart attack
A 73-year-old New Holland resident started getting short of breath and felt his lungs burning when he walked and ended up having heart attack ...
- Research reveals undertreatment of women with heart disease
Women with heart disease are less often treated with cholesterol-lowering drugs than men, according to research presented today at ESC Preventive Cardiology 2024, a scientific congress of the European ...
- Study: Women with heart disease prescribed cholesterol-lowering drugs less often than men
Women with heart disease may be prescribed cholesterol-reducing statins less frequently than men, contravening recommended treatment guidelines, according to new research released Thursday.
- Women with heart disease are less likely to receive life-saving drugs than men, researchers find
Despite having the same recommendations for treatment and for target levels of low-density ... and who had never had a heart attack. The median age was 68 years in men and 70 years in women.
- Women’s Heart Disease Is Under-Diagnosed, But New Scoring System Could Help Solve This Problem
The scoring system used to predict a person’s risk of cardiovascular disease needs to get an upgrade to ensure it accounts for risk factors specifically affecting women, according to a study published ...
Go deeper with Google Headlines on:
Heart attack treatment
[google_news title=”” keyword=”heart attack treatment” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]